CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• EPS Cop. Y/Y Annual
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 
 

PPBT's EPS from Cont. Operations Growth by Quarter and Year

Purple Biotech Ltd 's EPS from Cont. Operations results by quarter and year




PPBT EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 0.00 0.00 2.44 0.30
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.00 0.00 2.44 0.30



PPBT EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Comment
Purple Biotech Ltd in the fourth quarter 2022 recorded EPS loss from Cont. Operations of $ 0.00 .

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 18 other companies have achieved higher EPS from Cont. Operations growth. While Purple Biotech Ltd ' s EPS from Cont. Operations no change of % ranks overall at the positon no. 1120 in the fourth quarter 2022.


PPBT EPS from Cont. Operations ( Y/Y Growth %) 2022
 2021 2020 2019
IV Quarter December - - 713.33 % -23.08 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - 713.33 % -23.08 %

Financial Statements
Purple Biotech Ltd 's fourth quarter 2022 EPS from Cont. Operations $ 0.00 PPBT's Income Statement
Purple Biotech Ltd 's fourth quarter 2021 EPS from Cont. Operations $ 0.00 Quarterly PPBT's Income Statement
New: More PPBT's historic EPS from Cont. Operations Growth >>


PPBT EPS from Cont. Operations (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - 713.33 % -23.08 %


Go to PPBT financial reports >> Back to PPBT Growth rate Comparisons >>


EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #19
Healthcare Sector #76
Overall #1120

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
713.33 % 345.13 % -23.08 %
(Dec 31 2020)   (Dec 31 2019)
EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #19
Healthcare Sector #76
Overall #1120
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
713.33 % 345.13 % -23.08 %
(Dec 31 2020)   (Dec 31 2019)

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Purple Biotech Ltd 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q EPS from Cont. Operations Comment


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q EPS from Cont. Operations Comment


Purple Biotech Ltd 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2022)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
(Dec 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # 1120 # 0 # 0 # 0 # 1589
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 1120 # 0 # 0 # 0 # 1589

New: More PPBT's historic EPS from Cont. Operations Growth >>



Cumulative EPS from Cont. Operations growth Comment
In the Dec 31 2022 period, Purple Biotech Ltd 's cumulative trailing twelve month EPS from Cont. Operations remained unchanged compare to the same period a year ago.

In the Healthcare sector 75 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 1120.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
713.33 %
345.13 %
-23.08 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 19
Healthcare Sector # 76
Overall # 1120

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
713.33 %
345.13 %
-23.08 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 19
Sector # 76
S&P 500 # 1120
Cumulative EPS from Cont. Operations growth Comment
In the Dec 31 2022 period, Purple Biotech Ltd 's cumulative trailing twelve month EPS from Cont. Operations remained unchanged compare to the same period a year ago.

In the Healthcare sector 75 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 1120.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
713.33 %
345.13 %
-23.08 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 19
Healthcare Sector # 76
Overall # 1120

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
713.33 %
345.13 %
-23.08 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 19
Sector # 76
S&P 500 # 1120




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
PPBT's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for PPBT's Competitors
EPS from Cont. Operations Growth for Purple Biotech Ltd 's Suppliers
EPS from Cont. Operations Growth for PPBT's Customers

You may also want to know
PPBT's Annual Growth Rates PPBT's Profitability Ratios PPBT's Asset Turnover Ratio PPBT's Dividend Growth
PPBT's Roe PPBT's Valuation Ratios PPBT's Financial Strength Ratios PPBT's Dividend Payout Ratio
PPBT's Roa PPBT's Inventory Turnover Ratio PPBT's Growth Rates PPBT's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2022
Encompass Health Corporation-2.60%$ -2.599 
Inmode Ltd -3.45%$ -3.448 
Vanda Pharmaceuticals Inc -4.54%$ -4.543 
Amedisys Inc-6.60%$ -6.603 
Iradimed Corporation-6.71%$ -6.706 
Vascular Biogenics Ltd -7.44%$ -7.437 
Eton Pharmaceuticals Inc -8.34%$ -8.343 
Lemaitre Vascular Inc -9.47%$ -9.470 
Amgen Inc -10.28%$ -10.281 
Polypid Ltd -10.53%$ -10.526 
Alcon inc -11.69%$ -11.688 
Bristol myers Squibb Company-12.06%$ -12.060 
Intuitive Surgical Inc -13.05%$ -13.054 
Acadia Healthcare Company Inc -13.87%$ -13.872 
Steris Plc-13.89%$ -13.889 
Stryker Corp-14.98%$ -14.980 
Envista Holdings Corporation-15.28%$ -15.279 
Pharming Group N v -16.00%$ -16.000 
Qiagen N v -17.33%$ -17.333 
Uniqure N v -18.15%$ -18.153 
Universal Health Services Inc -19.04%$ -19.040 
Merck and Co Inc -19.65%$ -19.652 
Chemed Corporation-21.29%$ -21.292 
Atrion Corporation-21.89%$ -21.886 
Orgenesis Inc -22.47%$ -22.472 
Integer Holdings Corporation-24.16%$ -24.155 
Baxter International Inc -24.70%$ -24.703 
Integrated Biopharma Inc-25.00%$ -25.000 
Becton Dickinson And Company-25.65%$ -25.652 
Syneos Health Inc -26.32%$ -26.321 


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com